Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

February 12, 2016 8:09 AM ET

Capital Markets

Company Overview of CAM Capital

Company Overview

CAM Capital is a principal investment firm specializing in private and public market direct investments. The firm is sector agnostic with a focus on special situations. It seeks to make investments primarily in the Americas and Western Europe. The firm invests both independently and in collaboration with external partners. CAM Capital was founded in 2012 and is based in New York, New York.

1330 Sixth Avenue

Floor 20

New York, NY 10019

United States

Founded in 2012



Key Executives for CAM Capital

Founder and Chairman
Age: 70
Chief Financial Officer
Managing Director
Age: 39
Chief Investment Officer
Compensation as of Fiscal Year 2015.

CAM Capital Key Developments

CAM Capital Presents at ICV Manhattan Conference, Dec-09-2015 12:45 PM

CAM Capital Presents at ICV Manhattan Conference, Dec-09-2015 12:45 PM. Venue: Mandarin Oriental, 80 Columbus Circle at 60th Street, New York, NY 10023, United States. Speakers: Scott Morenstein, Managing Director.

Mevion Medical Systems, HOPU Investments, YuanMing Capital, Caxton Alternative Management L.P., ProQuest Investments, Venrock and CHL Medical Partners Forms Joint Venture to Produce, Sell and Service Proton Therapy Systems for the Chinese Market

Mevion Medical Systems announced that it has entered into an investment agreement where up to $200 million will be invested in Mevion to accelerate its worldwide expansion. The investment was led by HOPU Investments, YuanMing Capital, and participated in by other Chinese investors and existing U.S. investors Caxton Alternative Management L.P., ProQuest Investments, Venrock and CHL Medical Partners. Concurrent with the investment, Mevion and the lead investors will form a joint venture in China to produce, sell and service proton therapy systems for the Chinese market. HOPU and YuanMing have extensive experience investing in successful healthcare companies and offer a significant network of healthcare experience in China.

Similar Private Companies By Industry

Company Name Region
Grace 3, Inc. United States
Odeon Capital Group LLC, Research Division United States
C.B. Unterberg, Towbin United States
The Beryl Consulting Group LLC United States
The McLean Group, LLC United States

Recent Private Companies Transactions

Private Placement
November 23, 2015
Velicept Therapeutics, Inc.
Private Placement
July 24, 2015
Mevion Medical Systems, Inc.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact CAM Capital, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at